Ministries want less waiting for clinical trials

Shortening time that regulators take approving trials on experimental drugs will advance Israeli medical experimentation.

By
May 7, 2013 03:22
1 minute read.
Hospital beds [illustrative photo]

Hospital beds. (photo credit: Ariel Jerozolimski)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Red tape involving clinical trials for new medical technologies is being cut by the Health and Finance Ministries, they announced on Thursday.

Shortening the time that regulators take to approve the trials on experimental drugs and medical equipment will advance Israeli medicine and encourage experimentation here rather than in various countries abroad.

Be the first to know - Join our Facebook page.


The ministries stated that shortening the regulatory procedures on clinical trials here will “make it easier for researchers to get their work done, reduce costs for pharmaceutical companies and promote the competitive abilities of Israeli companies in the international landscape.”

The process of Health Ministry approval for launching clinical trials will take a maximum of 90 days instead of hundreds of days as in the past. Applicants will be able to apply for clinical trials directly through the Health Ministry and hospitals, instead of the current requirement of going through hospitals only.

The ministry also promised to improve its system of preparation and supervision throughout the whole procedure.

It will also promote transparency of information and decision making, and strengthen the network of expert advisers and the regulatory institutions, the ministries said.

The fast-tracking of the process and bringing it in coordination with standards abroad will increase the number and improve the functioning of young Israeli companies that carry out clinical trials here, the ministries said. In doing so, more international companies will be incentivized to set up research and development centers in Israel, and new medical technology jobs will be established.



The two ministries set up a joint steering committee that examined all the regulatory processes involved in clinical trials – including a look at what is done in advanced countries abroad – and identified what has caused delays.

Related Content

Lab
August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice

By JUDY SIEGEL-ITZKOVICH